1. Home
  2. SGBX vs LIXT Comparison

SGBX vs LIXT Comparison

Compare SGBX & LIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGBX
  • LIXT
  • Stock Information
  • Founded
  • SGBX 2007
  • LIXT 2005
  • Country
  • SGBX United States
  • LIXT United States
  • Employees
  • SGBX N/A
  • LIXT N/A
  • Industry
  • SGBX RETAIL: Building Materials
  • LIXT Biotechnology: Pharmaceutical Preparations
  • Sector
  • SGBX Consumer Discretionary
  • LIXT Health Care
  • Exchange
  • SGBX Nasdaq
  • LIXT Nasdaq
  • Market Cap
  • SGBX 2.7M
  • LIXT 3.0M
  • IPO Year
  • SGBX 2017
  • LIXT N/A
  • Fundamental
  • Price
  • SGBX $0.65
  • LIXT $0.74
  • Analyst Decision
  • SGBX
  • LIXT
  • Analyst Count
  • SGBX 0
  • LIXT 0
  • Target Price
  • SGBX N/A
  • LIXT N/A
  • AVG Volume (30 Days)
  • SGBX 1.6M
  • LIXT 82.2K
  • Earning Date
  • SGBX 06-13-2025
  • LIXT 08-07-2025
  • Dividend Yield
  • SGBX N/A
  • LIXT N/A
  • EPS Growth
  • SGBX N/A
  • LIXT N/A
  • EPS
  • SGBX N/A
  • LIXT N/A
  • Revenue
  • SGBX $4,574,857.00
  • LIXT N/A
  • Revenue This Year
  • SGBX $1,628.82
  • LIXT N/A
  • Revenue Next Year
  • SGBX N/A
  • LIXT N/A
  • P/E Ratio
  • SGBX N/A
  • LIXT N/A
  • Revenue Growth
  • SGBX N/A
  • LIXT N/A
  • 52 Week Low
  • SGBX $0.30
  • LIXT $0.64
  • 52 Week High
  • SGBX $3.75
  • LIXT $3.00
  • Technical
  • Relative Strength Index (RSI)
  • SGBX 45.31
  • LIXT 30.79
  • Support Level
  • SGBX $0.60
  • LIXT $0.64
  • Resistance Level
  • SGBX $0.97
  • LIXT $0.93
  • Average True Range (ATR)
  • SGBX 0.12
  • LIXT 0.13
  • MACD
  • SGBX -0.03
  • LIXT -0.05
  • Stochastic Oscillator
  • SGBX 19.90
  • LIXT 16.99

About SGBX Safe & Green Holdings Corp.

Safe & Green Holdings Corp is a modular solutions company. The company currently provides modules made out of both code-engineered cargo shipping containers and wood for use as both permanent or temporary structures for residential housing use and commercial use, including for health care facilities. It operates in four segments: construction services; medical; real estate development; and environmental. The company generates the majority of its revenue from the Construction segment includes the company's manufacturing unit SG ECHO and other modules projects.

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

Share on Social Networks: